Health & Research Goals
CJC-1295 + Ipamorelin Blend
Mezcla CJC-1295 + Ipamorelina
GH Secretagogue Dual Blend
Select a vial or the total
Primary Description
General research of a combined systemic protocol where each peptide exponentially amplifies the catalytic or hormonal pathway of the other, producing the most forceful response of the investigated vector.
Demonstrated Effects
- 3-5x greater GH pulse vs single compound
- Improved body composition (muscle mass, fat loss)
- Enhanced recovery and tissue repair
- Selective GH release — no cortisol or prolactin elevation
- Better sleep quality and energy levels
Proposed Mechanisms of Action
Combined Mechanism
CJC-1295 No-DAC (modified GHRH 1-29 fragment without Drug Affinity Complex) binds GHRH receptors on pituitary somatotroph cells, extending the natural GH pulse duration without prolonged receptor saturation. Ipamorelin mimics ghrelin at the GHS-R1a receptor via the phospholipase C pathway, triggering independent GH pulses. The two mechanisms are additive and synergistic: GHRH amplification + GHRP stimulation simultaneously, producing 3-5x greater GH output than either alone while maintaining cortisol and prolactin selectivity.
Stack Compounds
Research Evidence & Clinical Data
Research Profile
The most widely used GH optimization stack in peptide research. CJC-1295 No-DAC extends the GHRH pulse window while Ipamorelin selectively amplifies GH release without cortisol or prolactin elevation. Together they produce physiological GH pulses 3-5x greater than either compound alone, pre-mixed in a single vial for convenience.
Scientific References
- 1.
- 2.Ipamorelin, the first selective growth hormone secretagogueEur J Endocrinol1998
Safety Profile
Common Side Effects
- Transient water retention, especially at higher doses
- Mild fatigue or lethargy during the first 1-2 weeks
- Increased hunger (Ipamorelin ghrelin receptor effect)
- Potential for elevated IGF-1 — monitor with bloodwork every 3 months
- Inject at bedtime to align with natural GH pulse for optimal results
Contraindications
- Active malignancy (GH can promote tumor growth)
- Acromegaly or gigantism
- Diabetic retinopathy
- Pregnancy or breastfeeding
Analytical Quality Assurance
Research Protocols
Dosing Protocols
Standard Dosing Protocol
Subcutaneous (abdomen, thigh, or upper arm)Administration
Add 2mL bacteriostatic water to vial. Gently swirl (do not shake). Yields 250mcg CJC + 250mcg Ipamorelin per 0.1mL.
Unconstituted: -20°C freezer. Reconstituted: 2–8°C refrigerator, use within 30 days.
Evening/before bed (enhances natural nocturnal GH pulse) OR morning fasted + evening.
Rotate sites to prevent lipohypertrophy and maintain absorption. Abdomen, thighs, upper arms.
Administration Guidelines
| Parameter | Recommendation |
|---|---|
| Injection Route | Rotate sites to prevent lipohypertrophy and maintain absorption. Abdomen, thighs, upper arms. |
| Needle Size | 29–31G, 0.5-inch insulin syringe |
| Timing | Evening/before bed (enhances natural nocturnal GH pulse) OR morning fasted + evening. |
| Fasting Requirement | Inject on empty stomach (2–3 hours after last meal); wait 20–30 min before eating. |
| Storage | Unconstituted: -20°C freezer. Reconstituted: 2–8°C refrigerator, use within 30 days. |
Expectations Timeline
Week 1–2: Initial Adaptation
- Improved sleep quality, deeper slow-wave sleep, enhanced recovery
- Some users report vivid dreams
- Minimal body composition changes yet
Week 3–4: Early Benefits
- Increased energy, improved skin texture/elasticity, enhanced workout recovery
- IGF-1 levels begin rising (measure at week 4)
Month 2–3: Measurable Changes
- Noticeable body composition improvements (lean mass gain, fat loss)
- Enhanced strength, improved hair/nail growth
- IGF-1 typically elevated 50–100+ ng/mL
Month 4–6: Peak Effects
- Significant body recomposition, optimized metabolic function
- Sustained energy and vitality
- Most users report this as the "sweet spot" for benefits
Optimization Tips
- Fasting state: Always inject on empty stomach for maximum GH release
- Sleep optimization: Evening dosing enhances natural nocturnal GH pulse
- Exercise timing: Inject post-workout for enhanced recovery and anabolism
- Avoid glucose: High blood sugar blunts GH release; maintain low-carb pre-injection
- Rotate injection sites: Prevents lipohypertrophy and maintains absorption
Monitoring & Risk Management
Compound Stack Monitoring
For stacks and blends, refer to the individual compound monographs for each included ingredient for specific monitoring guidelines.